In:
Proceedings of the National Academy of Sciences, Proceedings of the National Academy of Sciences, Vol. 101, No. 49 ( 2004-12-07), p. 17204-17209
Abstract:
In human prostate cancer, the frequent down-regulation of p27 kip1 protein expression is correlated with poor clinical outcome, yet p27 kip1 rarely undergoes mutational inactivation. Here, we investigate the consequences of reducing or eliminating p27 kip1 function for prostate carcinogenesis in the context of a mouse modeling lacking the Nkx3.1 homeobox gene and the Pten tumor suppressor. Unexpectedly, we find that triple mutant mice heterozygous for a p27 kip1 null allele ( Nkx3.1 +/– or –/– ; Pten +/– ; p27 +/– ) display enhanced prostate carcinogenesis, whereas mice that are homozygous null for p27 kip1 ( Nkx3.1 +/– or –/– ; Pten +/– ; p27 –/– ) show inhibition of cancer progression. Expression profiling reveals that Cyclin D1 is highly up-regulated in compound p27 kip1 heterozygotes, but is down-regulated in the compound p27 kip1 homozygous mutants. Using RNA interference in prostate cancer cell lines with distinct p27 kip1 gene doses, we show that prostate tumorigenicity depends on levels of p27 kip1 and that the consequences of p27 kip1 gene dosage can be attributed, in part, to altered levels of Cyclin D1. Our findings suggest that p27 kip1 possesses dosage-sensitive positive as well as negative modulatory roles in prostate cancer progression.
Type of Medium:
Online Resource
ISSN:
0027-8424
,
1091-6490
DOI:
10.1073/pnas.0407693101
Language:
English
Publisher:
Proceedings of the National Academy of Sciences
Publication Date:
2004
detail.hit.zdb_id:
209104-5
detail.hit.zdb_id:
1461794-8
SSG:
11
SSG:
12
Permalink